This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
When radiologists interpretations are indeterminate, a commercially available deep learning algorithm could find clinically significant prostate cancer with improved specificity while maintaining sensitivity, suggested research published March 11 in Radiology. A majority (179) of participants underwent multiparametric MRI, the authors noted.
Columbia University researchers in New York City have reported that worsening depression in older adults is related to higher levels of Alzheimers disease pathology, specifically the accumulation of tau protein. The study was published April 9 in the American Journal of Geriatric Psychiatry. The full study can be found here.
AI-guided point-of-care ultrasound (POCUS) can accurately detect tuberculosis (TB), according to research presented April 14 at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) conference in Vienna, Austria. The technology may have applications in clinically underserved areas, Suttels said.
Deuterium metabolic imaging (DMI) was highly aligned with F-18 FDG-PET -- a cornerstone of dementia diagnostics -- in patients with Alzheimer's disease in a study published April 8 in Radiology. They compared the DMI results to clinical FDG-PET data from patient records. A graphical abstract of the study. Image courtesy of RSNA.
Patients with less tau pathology on PET scans may respond better to treatment with the new Alzheimer’s disease drug donanemab, according to an October 25 news report in the journal Practical Neurology. Food and Drug Administration, with a decision expected by the end of 2023. Donanemab is currently under review for approval by the U.S.
Welcome to the first installment of this year’s Road to RSNA preview of the RSNA 2023 meeting. AI’s capability and potential to enhance the practice of radiology will take center stage at RSNA 2023. For more information on those presentations and other abstracts, check out the RSNA 2023 meeting program. 9:40 a.m. | 9:40 a.m. |
And 2023 is no exception. The technology figured prominently in five Minnies categories, including Hottest Clinical Procedure. Workforce shortages were deemed by our Expert Panel to be the biggest threat in 2023. Each year, the Minnies award winners reflect the current challenges, issues, and advances in radiology.
Exciting presentations will cover a generative AI model that shows potential for making surgical planning for total hip arthroplasty (THA) more efficient and a deep-learning model developed to identify individuals at high risk of chronic obstructive pulmonary disease (COPD). 1:10 p.m. | 2:00 p.m. | 3:20 p.m. | 8:40 a.m. | 9:20 a.m. |
An automated segmentation tool called TotalSegmentator CT was released in August 2023, and since then there has been demand for a similar tool that can be applied across all MRI sequences and anatomic structures, the group explained. To this end, D'Antonoli and colleagues built TotalSegmentator MRI, which they based on nnU-Net.
Photon-counting CT may serve as an alternative to MRI for assessing liver fat in patients with fatty liver disease, according to an article published September 24 in Radiology. The disease affects up to 24% of the population in the U.S. and can lead to cirrhosis and even cancer if left untreated. in the MASLD cohort.
CHICAGO -- GE HealthCare (GEHC) brought new CT and MRI scanners and a range of AI software applications to McCormick Place for RSNA 2023. Interventional In image-guided surgery activities, GEHC showcased two new AI applications previously presented at ECR 2023. MRI GEHC unveiled Signa Champion, a 1.5-tesla,
“The significantly higher lesion-based sensitivity in unsuspected metastases implies a future role of F-18 FAPI PET/CT in evaluation of metastatic disease burden,” the team wrote. The retrospective analysis included data collected in 2022 and 2023 from 38 women with initial clinical stage IIB-IIIC breast cancer. for F-18 FDG.
Continuing to expand its ultrasound AI capabilities, GE HealthCare has signed an agreement to acquire Wales-based Intelligent Ultrasound Group's clinical AI software business for total consideration of approximately $51 million. Intelligent Ultrasound Chief Operating Officer Nick Sleep will also come over to GE HealthCare.
OpenAI's GPT-4 AI model can utilize imaging reports to generate summaries of disease course in patients with complex glioblastoma, improving treatment planning and potentially even enhancing radiology workflows, according to research published July 23 in Radiology. No image data were transmitted to GPT-4.
milla1cf Wed, 08/02/2023 - 19:58 August 2, 2023 — An accepted manuscript published in the American Journal of Roentgenology (AJR) found that deploying a radiomic-based model with T2-weighted MRI data could increase diagnostic accuracy for pediatric Crohn disease (CD). Dillman , MD, MSc. Dillman et al.’s and accuracy of 89.6%.
Researchers from Cedars-Sinai Medical Center in Los Angeles are among those monitoring the clinical and investigational role of AI in advanced cardiac CT imaging. Researchers provided the resulting risk scores to doctors for 744 patients. Among the takeaways: In up to 45% of cases, doctors altered their patients' treatment plans as a result.
in 2023 to 16% in 2024 -- a shift likely due to a change in methodology, according to researchers. Centers for Disease Control and Prevention and consists of information from more than 400,000 interviews with adults each year. The BRFSS is a telephone-based health survey conducted by the U.S.
Based on a novel clustering framework using sparse canonical correlation analysis (SCCA), the integrated approach was successful in identifying four subtypes of Alzheimer’s disease and the top genes associated with each, according to the authors of the study, “An SCCA-clustering framework for Alzheimer’s disease subtyping using tau PET and genomics.”
christine.book Mon, 06/26/2023 - 12:46 June 26, 2023 — PET imaging with 68Ga-FAPI offers a feasible, reliable, and reproducible method for evaluating disease activity in rheumatoid arthritis, according to new research presented at the 2023 Society of Nuclear Medicine and Molecular Imaging Annual Meeting.
They extracted total kidney volume (TKV) from images at three and six months after treatment using an AI tool called TotalSegmentator, a freely available segmentation AI model developed by a Swiss team in 2023. In total, 363 CT studies were included, comprising 121 baseline and 242 follow-up scans. The full study is available here.
As of January 2023, hybrid iterative reconstruction (HIR) -- a blend of FBP and MBIR -- was the state-of-the-art image reconstruction technique, according to Lennart Koetzier; Martin Willemink, PhD; and colleagues, who wrote about the technical principles and clinical prospects for the RSNA journal Radiology. Tim Leiner, MD, PhD.
Most Influential Radiology Researcher Erik Middlebrooks, MD, Mayo Clinic, Jacksonville, FL Erik Middlebrooks, MD. One of this year's nominations for Most Influential Radiology Researcher is Erik Middlebrooks, MD, of the Mayo Clinic in Jacksonville, FL. But we're still just scratching the surface." Elliot Fishman, MD.
Other partnerships like this] have demonstrated increased patient satisfaction and understanding of their disease process and treatment options through the establishment of multidisciplinary clinics." The final study sample consisted of 579,153 procedures. The complete study can be found here.
Chinese clinicians have provided evidence in a “real-world study” that shows amyloid PET imaging is effective for diagnosing and managing patients with Alzheimer’s disease, according to a study published February 8 in Alzheimer’s and Dementia. The clinical utility of amyloid PET scans has been systematically studied in many other countries.
The authors of a practical guide designed to help radiologists avoid malpractice claims have received one of 17 magna cum laude awards handed out by the RSNA 2023 judges. RSNA 2023 registrants can read the malpractice poster here. Another prizewinner is about imaging of syphilis.
While care must be individualized, for patients with unknown or unestablished coronary artery disease, the transition to a 'CT first' strategy should be a high priority for cardiovascular care providers," he said. Most study participants were male and white.
RT (R)(T) | Clinical Applications Specialist, Carestream The U.S. Centers for Disease Control and Preventions National Institute for Occupational Safety and Health (NIOSH) is deciding on expanding their federal program known as the B Reader Program. Compared to only 500 hours of clinical experience for NPs and 2000 hours for PAs.
Is there a signature biomarker for younger/early-onset Alzheimer’s Disease (EOAD)? Sporadic early-onset Alzheimer’s disease (EOAD) is rare and understudied. What Are the Clinical Implications? We were able to prove that the EOAD signature is a clinically valid measure of AD-related neurodegeneration.
There is no cure for the disease, with treatments designed to prolong the lives of patients. Current evidence The best evidence so far on the sequence for these treatments comes from the so-called “RaLu Study,” a medical chart review analysis published in December 2023 in the Journal of Nuclear Medicine. Now there’s Pluvicto, she said.
milla1cf Tue, 09/26/2023 - 15:32 September 26, 2023 — In a study of more than 2,000 chest X-rays , radiologists outperformed AI in accurately identifying the presence and absence of three common lung diseases, according to a study published in Radiology , a journal of the Radiological Society of North America ( RSNA ).
Food and Drug Administration has approved this technology for the treatment of essential tremor and Parkinson's disease, and its indications are expanding to include various intracranial diseases. High-intensity FUS is a safe and effective treatment for various intracranial diseases.
FAPI-PET either confirmed or ruled out the disease in all cases, the group found. CT and F-18 FDG-PET are considered clinical gold standards for lung cancer imaging, yet several subtypes of lung cancer, especially the lepidic subtype, are frequently negative on these scans. Access to the full study is available here.
Max Lahaye, MD, of the Netherlands Cancer Institute in Amsterdam presents findings on the clinical impact of dedicated MR staging of ovarian cancer patients during ECR 2024. that every visible disease has to be removed surgically," Lahaye said. We as radiologists have a problem in depicting disease on CT, peritoneal disease.
In 2023, an estimated 8.3 Regarding the breakdown of patient case mix by department, the report found that in 2023, 51% of fixed C-arm cases were performed in radiology-related departments, 35% in cardiology-related departments, and 15% in surgery-related departments. Davin Korstjens of IMV Medical Information Division.
AI may have a role in finding contralateral disease in women with a personal history of breast cancer, according to findings published April 8 in Radiology. The women were diagnosed between 2001 and 2018 and underwent post-mastectomy surveillance mammography between 2011 and 2023. Sensitivity 55.0% Specificity 98.1%
LifeQ offers a 24/7 lens into the body, generating actionable health insights from personal wearable devices and assisting in screening for disease and illness and uncovering its root cause," stated Laurie Olivier, LifeQ CEO and co-founder.
These changes are beyond what can be evaluated by clinical measures such as weight and waist circumference, wrote a team led by Leslie W. Nelson, DO, of the University of Wisconsin in Madison. "[We The study findings add to current research regarding Ozempic's efficacy, according to Nelson's team. "By The complete study can be found here.
christine.book Tue, 10/03/2023 - 11:37 October 3, 2023 — Medical device company GT Medical Technologies, Inc. 2 poster presentation at the American Society for Radiation Oncology's (ASTRO) 65th Annual Meeting, ASTRO 2023 , being held this week in San Diego, CA.
milla1cf Mon, 09/25/2023 - 15:57 September 25, 2023 — Viz.ai , a leader in AI -powered disease detection and intelligent care coordination, today announced new clinical data supporting advancements in pulmonary embolism (PE) detection. For more information: https ://www.viz.ai/vascular
The Boston, MA-based company has announced multiple sessions to demonstrate its industry-leading Clinical Natural Language Understanding (cNLU) technology at HIMSS 2023. Doctor vs. AI: Clinical Natural Language Processing for Preoperative Care — Join Kevin Agatstein and Dr. CT) at the McCormick Center, South Building S104.
In ultrasound, GEHC is debuting Logiq Totus, a midrange, full-body scanner designed for use in a variety of clinical scenarios. The wide-bore system was initially introduced at RSNA 2023. VIENNA – GE HealthCare (GEHC) is highlighting a revamped ultrasound product line, the European launch of its Signa Champion 1.5-tesla
milla1cf Fri, 06/02/2023 - 20:28 June 2, 2023 — Philips has entered into a collaboration with medical imaging company Polarean to advance the field of hyperpolarized Xenon MRI for patients with respiratory illness. In theory, any atomic element with a sufficient degree of magnetic polarization can be detected in an MRI scanner.
S3A-SPBR-7 | Learning Center Compared with ultrasound or MRI used alone to diagnose breast diseases, a combined model of both modalities based on radiomics more accurately identifies breast conditions, according to a poster to be displayed Sunday morning. Sunday, December 1 | 11:45 a.m.-12:15 12:15 p.m. |
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content